Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme
- PMID: 19265196
- PMCID: PMC2673266
- DOI: 10.1074/jbc.M808761200
Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme
Abstract
In this study, we attempted to understand the mechanism of regulation of the activity and allosteric behavior of the pyruvate kinase M(2) enzyme and two of its missense mutations, H391Y and K422R, found in cells from Bloom syndrome patients, prone to develop cancer. Results show that despite the presence of mutations in the intersubunit contact domain, the K422R and H391Y mutant proteins maintained their homotetrameric structure, similar to the wild-type protein, but showed a loss of activity of 75 and 20%, respectively. Interestingly, H391Y showed a 6-fold increase in affinity for its substrate phosphoenolpyruvate and behaved like a non-allosteric protein with compromised cooperative binding. However, the affinity for phosphoenolpyruvate was lost significantly in K422R. Unlike K422R, H391Y showed enhanced thermal stability, stability over a range of pH values, a lesser effect of the allosteric inhibitor Phe, and resistance toward structural alteration upon binding of the activator (fructose 1,6-bisphosphate) and inhibitor (Phe). Both mutants showed a slight shift in the pH optimum from 7.4 to 7.0. Although this study signifies the importance of conserved amino acid residues in long-range communications between the subunits of multimeric proteins, the altered behavior of mutants is suggestive of their probable role in tumor-promoting growth and metabolism in Bloom syndrome patients with defective pyruvate kinase M(2).
Figures








Similar articles
-
Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner.J Biol Chem. 2014 Mar 21;289(12):8098-105. doi: 10.1074/jbc.M113.515742. Epub 2014 Feb 3. J Biol Chem. 2014. PMID: 24492614 Free PMC article.
-
Dominant negative effect of novel mutations in pyruvate kinase-M2.DNA Cell Biol. 2004 Jul;23(7):442-9. doi: 10.1089/1044549041474797. DNA Cell Biol. 2004. PMID: 15294093
-
Conversion of non-allosteric pyruvate kinase isozyme into an allosteric enzyme by a single amino acid substitution.J Biol Chem. 1997 Aug 15;272(33):20495-501. doi: 10.1074/jbc.272.33.20495. J Biol Chem. 1997. PMID: 9252361
-
Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.Blood. 2001 Nov 15;98(10):3113-20. doi: 10.1182/blood.v98.10.3113. Blood. 2001. PMID: 11698298
-
An overview of structure, function, and regulation of pyruvate kinases.Protein Sci. 2019 Oct;28(10):1771-1784. doi: 10.1002/pro.3691. Epub 2019 Aug 12. Protein Sci. 2019. PMID: 31342570 Free PMC article. Review.
Cited by
-
Cancer-associated mutations in human pyruvate kinase M2 impair enzyme activity.FEBS Lett. 2020 Feb;594(4):646-664. doi: 10.1002/1873-3468.13648. Epub 2019 Nov 16. FEBS Lett. 2020. PMID: 31642061 Free PMC article.
-
Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.Open Biol. 2022 Sep;12(9):220179. doi: 10.1098/rsob.220179. Epub 2022 Sep 21. Open Biol. 2022. PMID: 36128717 Free PMC article.
-
Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon?Oncoscience. 2014 Apr 21;1(4):287-95. doi: 10.18632/oncoscience.29. eCollection 2014. Oncoscience. 2014. PMID: 25594021 Free PMC article.
-
Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.Cancer. 2013 Feb 1;119(3):575-85. doi: 10.1002/cncr.27611. Epub 2012 Aug 1. Cancer. 2013. PMID: 22864959 Free PMC article.
-
Human pyruvate kinase M2: a multifunctional protein.Protein Sci. 2010 Nov;19(11):2031-44. doi: 10.1002/pro.505. Protein Sci. 2010. PMID: 20857498 Free PMC article. Review.
References
-
- Kayne, F. J., and Price, N. C. (1973) Arch. Biochem. Biophys. 159 292–296 - PubMed
-
- Kuo, D. J., O'Connell, E. L., and Rose, I. A. (1979) J. Am. Chem. Soc. 101 5025–5030
-
- Valentini, G., Chiarelli, L., Fortin, R., Speranza, M. L., Galizzi, A., and Mattevi, A. (2000) J. Biol. Chem. 275 18145–18152 - PubMed
-
- Mazurek, S., Boschek, C. B., and Eigenbrodt, E. (1997) J. Bioenerg. Biomembr. 29 315–330 - PubMed
-
- Imamura, K., and Tanaka, T. (1982) Methods Enzymol. 90 150–165 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources